Published on
May 8, 2026
- 11:58 GMT
CORD FOR LIFE® COMPLETES PHASE 1 DOSING IN FDA AUTHORIZED SACROILIAC JOINT (SIJ) SYNDROME - CLINICAL TRIAL
Cord for Life® completes Phase 1 dosing for its FDA-authorized clinical trial using cord blood to treat lower back pain from Sacroiliac Joint (SIJ) Syndrome. ALTAMONTE SPRINGS, FL, UNITED STATES, May 8, 2026 /EINPresswire.com/ -- ALTAMONTE SPRINGS, FL ( …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
